• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
India Pharmaceuticals and Healthcare Report Q1 2011 - Product Image

India Pharmaceuticals and Healthcare Report Q1 2011

  • Published: January 2010
  • Region: India
  • 98 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Aurobindo Pharmaceutical
  • Dr Reddy’s Laboratories
  • Granules India
  • Novartis
  • Piramal Healthcare
  • Sanofi-Aventis
  • MORE

The India Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on India's pharmaceuticals and healthcare industry.

Underpinned by relative political stability and driven by a booming economy, India's pharmaceutical market is highly promising. Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase from INR739.3bn (US$15.65bn) in 2009 to INR837.7bn (US$18.05bn) in 2010.Due to the strengthening rupee, this equates to year-on-year (y-o-y) growth of 13.3% in local currency terms and 15.3% in US dollar terms.

BMI data show that India has the fourth largest pharmaceutical market in the Asia Pacific region, behind Japan, China and South Korea. However, per-capita spending of US$13.5 is among the lowest in the world, similar to the levels of Pakistan and Vietnam. Pharmaceutical expenditure in 2009 was 1.19% of GDP, which is below the global average of 1.43%.

Although India's score increased from 55.3 to 56.0 in the Asia Pacific Pharmaceuticals & READ MORE >

Executive Summary

SWOT Analysis
- India Pharmaceutical Industry SWOT
- India Political SWOT
- India Economic SWOT
- India Business Environment SWOT

India’s Pharmaceutical Business Environment Ratings
- Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q111
- Rewards
- Risks

India – Market Summary

Regulatory Environment
- Table: Responsibilities Of India’s Department Of Pharmaceuticals
- Pharmaceutical Advertising
- Pharmacovigilance
- IP Regime
- Table: History Of The Indian Patent System
- Patent Disputes
- Counterfeit Medicines
- Pricing And Reimbursement

Industry Trends And Developments
- Epidemiology
- Healthcare Sector
- Healthcare Funding
- Healthcare Insurance
- Research And Development
- Clinical Trials
- Recent Developments In The Clinical Trials Industry
- Active Pharmaceutical Ingredients
- Biotechnology Sector
- Traditional Medicines

Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2006-2014
- Key Growth Factors – Industry
- Table: Healthcare Expenditure Trends, Historical Data and Forecasts, 2006-2014
- Key Growth Factors – Macroeconomic
- Table: India – Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2006-2014
- Patented Drug Market Forecast
- Table: Patented Drug Sales Indicators 2006-2014
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2006-2014
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2006- 2014
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Exports Indicators 2006-2014
- Table: Pharmaceutical Imports Indicators 2006-2014
- Medical Device Market Forecast
- Table: Medical Device Sales Indicators 2006-2014
- Other Healthcare Data Forecasts
- Key Risks To BMI’s Forecast Scenario

Competitive Landscape
- Table: Top 25 Pharmaceutical Companies According To Sales In India
- Key Pharmaceutical Industry Developments

Company Profiles
- Leading Domestic Manufacturers
- Cipla
- Ranbaxy Laboratories
- Dr Reddy’s Laboratories
- Aurobindo Pharmaceutical
- Venus Remedies
- Granules India
- Piramal Healthcare
- Zydus Cadila
- Leading Multinational Manufacturers
- Pfizer
- GlaxoSmithKline (GSK)
- Novartis
- Sanofi-Aventis
- Merck & Co

Country Snapshot: India Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education and Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 1996-2001
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Manufacturing Wages, 2000-2012

BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceuticals Business Environment Ratings
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources

- Cipla

- Ranbaxy Laboratories

- Dr Reddy’s Laboratories

- Aurobindo Pharmaceutical

- Venus Remedies

- Granules India

- Piramal Healthcare

- Zydus Cadila

- Pfizer

- GlaxoSmithKline (GSK)

- Novartis

- Sanofi-Aventis

- Merck & Co

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos